89bio Clinical Study Site

Budapest H-1097

1 studies enrolling now · 2 studies all time

What they study most

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Severe Hypertriglyceridemia

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH — Recruiting now
• Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia — Completed